|
2020, Vol. 29(10): 827-832 DOI: 10.3760/cma.j.cn113030-20190520-00186 | ||
The role of concurrent chemotherapy in intensity-modulated radiotherapy for patients with stage Ⅲ nasopharyngeal carcinoma | ||
Wu Zheng1, Wang Lei2, Xie Dehuan3, Lyu Shaowen3, Su Yong3 | ||
1Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China; 2Department of Radiation Oncology, Shen Zhen People′s Hospital, Shenzhen 518020, China; 3Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou 510060, China |
||
Received 2019-05-20 Revised null | ||
Supporting info | ||
null | ||
|